ascendis pharma glp-1 receptor agonist weight management diabetes treatments medications Emerging Trends in the Development of GLP-1 Receptor Agonists Novo Nordisk, Ascendis Ink $285M

Qingshan Zheng and Lujin Li designed the research

If you want to avoid injections Oral semaglutide is your best bet

Transporter assays for SGLT1 (Sodium-GLUcose Transporter 1) and GLUT2 (Glucose Transporter 2) are also available

doi: 10.3389/fmed.2026.1752341 Received 23 November 2025 Revised 04 April 2026 Accepted 10 April 2026 Published 29 April 2026 Volume 13 - 2026 Edited by Wei Liu, Huazhong University of Science and Technology, China Reviewed by Jheng-Yan Wu, Chi Mei Medical Center, Taiwan Jennifer Teske, University of Arizona, United States Updates Copyright 2026 Fang, Zhu, Rao and Liu

Lancet 360 , 473482 (2002)

Strategies for managing GLP-1-related nausea apply to both peptides